University Of Texas Vir Biotechnology, Inc. Transaction History

University Of Texas

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$18.26 - $31.1 $2.38 Million - $4.06 Million	130,409 New	130,409 $2.51 Million
Q1 2022 May 06, 2022	SELL	$21.19 - $40.01 $6.16 Million - $11.6 Million	-290,736 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$30.97 - $54.03 $9 Million - $15.7 Million	290,736 New	290,736 $12.2 Million
Q2 2021 Aug 06, 2021	SELL	$38.75 - $51.0 $3.66 Million - $4.82 Million	-94,513 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$26.34 - $83.07 $2.49 Million - $7.85 Million	94,513 New	94,513 $4.85 Million

231

90.1M

1.28M

235K

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.26B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of University Of Texas, based on Form 13F filings with the SEC.

Stay updated on University Of Texas with notifications on news.